or
forgot password
  • cancer clinical trials in oklahoma

  • Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
    ProCure Proton Therapy Center
    Oklahoma City, Oklahoma 73142
    Prostate Cancer
    Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
    Southwestern Regional Medical Center

    Trial Locations
    Southwestern Regional Medical Center
    Tulsa Cancer Institute
    Metastatic Castration-Resistant Prostate Cancer
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    Natalie W Bryant Cancer Center
    Tulsa, Oklahoma 74136
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients
    University Of Oklahoma Peggy & Charles Stephenson Cancer Center

    Trial Locations
    University Of Oklahoma Peggy & Charles Stephenson Cancer Center
    Tulsa Cancer Institute, Pllc
    Ovarian Cancer
    Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
    Natalie W Bryant Cancer Center
    Tulsa, Oklahoma 74136
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Tumors Metastatic to Brain
    Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
    Integris-Baptist Medical
    Oklahoma City, Oklahoma 73112
    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Yale
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    Cancer Care Associates-Yale
    Tulsa, Oklahoma 74136-1929
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    Afatinib Expanded Access Program
    1200.45.089 Boehringer Ingelheim Investigational Site
    Tulsa, Oklahoma
    Carcinoma, Non-Small-Cell Lung
    A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

    Tulsa, Oklahoma
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    University of Oklahoma, Site #028
    Oklahoma City, Oklahoma 73104
    Chronic Myeloid Leukemia
    Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Natalie W Bryant Cancer Center
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Neurofibrosarcoma, Chondrosarcoma, Endometrial Stromal Sarcoma, Mast Cell Sarcoma, Metastatic Adult Malignant Fibrous Histiocytoma of Bone, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Adult Malignant Fibrous Histiocytoma of Bone, Recurrent Adult Soft Tissue Sarcoma, Small Intestine Leiomyosarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Natalie W Bryant Cancer Center
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Tulsa Cancer Institute
    Tulsa, Oklahoma 74136
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
    Universtiy of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cervical Cancer, Endometrial Cancer, Gastrointestinal Complications, Perioperative/Postoperative Complications, Radiation Toxicity, Urinary Complications, Urinary Tract Toxicity
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
    Investigational Site Number 840127

    Trial Locations
    Investigational Site Number 840127
    Investigational Site Number 840011
    Rheumatoid Arthritis
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Yale
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    Urologic Specialists of Oklahoma
    Tulsa, Oklahoma 74146
    Prostate Cancer
    Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Hemophilia A
    Proton Radiation for Stage III Breast Cancer
    ProCure Proton Therapy Center
    Oklahoma City, Oklahoma 73142
    Breast Cancer, Breast Neoplasm, Breast Tumor, Cancer of the Breast
    Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
    Oklahoma Foundation for Digestive Research
    Oklahoma City, Oklahoma 73104
    Ulcerative Colitis
    Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
    Southwestern Regional Medical Center, Inc.
    Tulsa, Oklahoma 74133
    Pancreatic Cancer
    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
    ProCure Proton Therapy Center
    Oklahoma City, Oklahoma 73142
    Breast Cancer, Breast Neoplasm, Breast Tumor, Cancer of the Breast
    Registry and Fluid Banking of Pancreatic Cystic Lesions
    Endoscopy Centrer at OU Medical Center
    Oklahoma City, Oklahoma 73104
    Pancreatic Cysts
    Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer
    Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Pancreatic Cancer, Pancreatic Carcinoma Non-resectable, Locally Advanced Malignant Neoplasm
    Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
    Clinical Investigations, LLC
    Edmond, Oklahoma 73013
    Compression Fracture of Vertebral Body, Osteoporosis, Cancer.
    RSSearch Registry-Long Term Study of Use of SRS/SBRT to Treat Tumors and Other Functional Diseases
    St Anthony's
    Oklahoma City, Oklahoma 73102
    Neoplasms, Arteriovenous Malformations, Trigeminal Neuralgia
    Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
    Stephensen Cancer Center
    Oklahoma City, Oklahoma 73104
    Pancreatic Cancer
    Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer, Ovarian Cancer
    Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Leukemia, Liver Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Psychosocial Effects of Cancer and Its Treatment, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
    Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Leukemia
    Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    St. John Medical Center
    Tulsa, Oklahoma 74104
    Brain and Central Nervous System Tumors
    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Sarcoma
    Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer, Vaginal Cancer
    Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Brain and Central Nervous System Tumors